Tel: +82 (0)70-4268-9066

Fax: +82 (0)2 430-5745

e-mail: K.miceteam@gmail.com

(28159) 187, Osongsaengmyeong 2-ro, Yeonje-ri, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

© 2018 by Ministry of Food and Drug Safety

Secretariat for Symposium & WHO Workshop
바이오의약품 GMP 국제 심포지엄 & 워크숍 사무국
International Symposium
on GMP for Biological products
WHO Workshop
on Implementation of GMP for Biological Products

18-21 September, 2018 ┃ Seoul, Republic of Korea

​About Symposium & Workshop

International Symposium on GMP for Biological products

Seoul, Republic of Korea
18 September, 2018

Venue: Sheraton Seoul Palace Gangnam Hotel Grand Ballroom B1F

Attendees: WHO Experts, Drafting Group, Manufacturers, Academia, Research Institutes

           

※ English-Korean simultaneous interpretation will be provided.

WHO Workshop on Implementation of GMP for Biological Products

19-21 September, 2018
Seoul, Republic of Korea

Venue: Sheraton Seoul Palace Gangnam Hotel Grand Ballroom B1F

Attendees: WHO Experts, Drafting Group, Regulators, Manufacturers

※ Please note that this informal consultation is a closed meeting for invited participants only.

<Welcome Message>

 

I cordially invite you to International Symposium on GMP for Biological Products.

 

With advances in scientific technologies, various types of biological products have been developed, steadily gaining global market share.

 

The NIFDS, since its designation as a WHO CC in biological standardization in 2011, has organized international meetings every year for the development and implementation of WHO global written standards in collaboration with WHO.

 

Held back-to-back with the 2nd WHO Workshop on Implementation of GMP Guidelines for Biological Products that invited regulatory experts from 11 countries to facilitate application of the revised GMP guidelines, the symposium will deal with a range of topics and pending issues with regard to bio-safety considerations, GMP for advanced therapeutic products in addition to the requirements prescribed in the revision of GMP guideline, which will be beneficial for both regulatory authorities and the industry.

 

Hoping that this symposium will contribute to improving understanding and fostering implementation of WHO GMP guidelines, I ask for your interest and participation to make this meeting an open forum for active exchanges and discussions on GMP for biological products.

Thank you.

 

 

Sunhee Lee

Director General

National Institute of Food and Drug Safety Evaluation

Registration & Contact

If you have any request or need our assistance,

please contact us.